Drug
Artemisinin
Artemisinin is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_2
1
25%
Ph phase_3
1
25%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
unknown125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_4
A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 Subjects
NCT05004753
unknownphase_2
A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects
NCT04801017
completedphase_3
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
NCT01391403
completednot_applicable
Artemisinin to Reduce The Symptoms of Schizophrenia
NCT00753506
Clinical Trials (4)
Showing 4 of 4 trials
NCT05004753Phase 4
A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 Subjects
NCT04801017Phase 2
A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects
NCT01391403Phase 3
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
NCT00753506Not Applicable
Artemisinin to Reduce The Symptoms of Schizophrenia
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4